Torrent Pharmaceuticals Limited is the flagship pharmaceutical company of the Torrent Group and one of India’s leading manufacturers of branded and generic medicines. Founded in 1959, the company has established a strong presence across more than 40 countries with expertise in cardiovascular, central nervous system, gastrointestinal, diabetes, anti-infective, oncology, and women’s healthcare therapies. Torrent Pharma combines robust research and development capabilities with advanced manufacturing facilities that meet stringent international regulatory standards. The company has steadily expanded through strategic acquisitions and product innovation, strengthening its position in both domestic and international markets. Its emphasis on specialty therapies, high-quality manufacturing, and patient-centric healthcare has contributed to sustained business growth. Torrent continues to invest in complex generics, lifecycle management, and digital transformation while maintaining a diversified portfolio of prescription medicines. The company’s commitment to innovation and operational excellence has established it as one of India’s most respected pharmaceutical organizations.
NSE: TORNTPHARM | BSE: 500420
Ahmedabad, Gujarat, India
~14,000 employees
